FDA Accepts NDA for Budesonide Rectal Foam Salix announced that the Food and Drug Administration (FDA) has granted tentative approval for Uceris (budesonide) rectal foam for the induction of remission ...

“ Distal ulcerative colitis can be challenging for patients to live with and gastroenterologists to treat. Our goal is to put the disease into remission so that patients can get on with their lives,” ...

Rectally administered topical agents have demonstrated efficacy in the maintenance of distal colitis (DC) and proctitis and as they are rarely associated with significant blood drug levels, side ...

ATLANTA--(BUSINESS WIRE)--sfRowasa™ (mesalamine) Rectal Suspension 4g/60mL –Sulfite-Free Formulation, is the first sulfite-free rectal suspension available for Ulcerative colitis (UC). According to a ...

UCERIS is now available for patients through the public drug plans of five Canadian provinces: Ontario, Quebec, Saskatchewan, New Brunswick and Nova Scotia. These first public drug plan listings for ...

LAVAL, QE / ACCESSWIRE / September 12, 2023 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is pleased to announce that following its approval by Health Canada the new treatment Pr UCERIS ® ...

Final Approval of Uceris Rectal Foam for Ulcerative Colitis Granted by FDA The Food and Drug Administration (FDA) has granted final approval for Uceris (budesonide; Salix) 2mg rectal foam for the ...

LAVAL, QC / ACCESSWIRE / May 23, 2024 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced additional Canadian public drug plan listings for Pr ...

Gas, constipation, bloating — if you have ulcerative colitis (UC), you may not want to share the details of unpleasant digestive symptoms with anyone. However, to start feeling better, you may need to ...

Once remission has been achieved, however, there is no evidence that steroid enemas will maintain the remission. [27] Thus with the risk of cumulative systemic absorption of topically administered ...